vaccinia-tyrosinase vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1999 (NCT00019734)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- TyrosinaseImmunity, active
TYR immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vaccinia-tyrosinase vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00054535 | Phase 2 | Jan 1, 2003 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT00019734 | Phase 2 | Jul 1, 1999 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 2 | 1 | 1999 |
| National Institutes of Health (NIH) | Government | 2 | 0 | 1 | 1999 |
2 organizations
Page 1 / 1